Page last updated: 2024-09-03

tak 044 and Brain Ischemia

tak 044 has been researched along with Brain Ischemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briyal, S; Gulati, A; Gupta, YK; Jagannathan, NR; Sharma, U1
Briyal, S; Gulati, A; Gupta, YK1
Bell, BA; Murray, GD; Pickard, JD; Shaw, MD; Teasdale, GM; Vermeulen, M1

Trials

1 trial(s) available for tak 044 and Brain Ischemia

ArticleYear
Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Journal of neurosurgery, 2000, Volume: 93, Issue:6

    Topics: Adult; Aged; Brain Ischemia; Double-Blind Method; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Glasgow Outcome Scale; Humans; Male; Middle Aged; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Subarachnoid Hemorrhage; Survival Rate; Vasospasm, Intracranial

2000

Other Studies

2 other study(ies) available for tak 044 and Brain Ischemia

ArticleYear
Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats.
    Life sciences, 2005, May-20, Volume: 77, Issue:1

    Topics: Animals; Behavior, Animal; Biomarkers; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Endothelins; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Motor Activity; Oxidative Stress; Peptides, Cyclic; Rats; Rats, Wistar; Superoxide Dismutase

2005
Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
    Methods and findings in experimental and clinical pharmacology, 2007, Volume: 29, Issue:4

    Topics: Animals; Antioxidants; Aspirin; Brain Ischemia; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Motor Activity; Neuroprotective Agents; Oxidative Stress; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Endothelin; Stroke; Superoxide Dismutase

2007